GADLEN Trademark

Trademark Overview

On Thursday, April 30, 2020, a trademark application was filed for GADLEN with the United States Patent and Trademark Office. The USPTO has given the GADLEN trademark a serial number of 88985123. The federal status of this trademark filing is REGISTERED as of Tuesday, July 25, 2023. This trademark is owned by Shattuck Labs, Inc.. The GADLEN trademark is filed in the Pharmaceutical Products category with the following description:

Goods derived from biotechnological platform technology, namely, biotechnological pharmaceutical, pharmaceutical, and therapeutic pharmaceutical preparations in the form of fusion proteins for treatment of cancer and autoimmune diseases
gadlen

General Information

Serial Number88985123
Word MarkGADLEN
Filing DateThursday, April 30, 2020
Status700 - REGISTERED
Status DateTuesday, July 25, 2023
Registration Number7122228
Registration DateTuesday, July 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesGoods derived from biotechnological platform technology, namely, biotechnological pharmaceutical, pharmaceutical, and therapeutic pharmaceutical preparations in the form of fusion proteins for treatment of cancer and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2020
Primary Code005
First Use Anywhere DateWednesday, April 26, 2023
First Use In Commerce DateWednesday, April 26, 2023

Trademark Owner History

Party NameShattuck Labs, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAustin, TX 78701
Party NameShattuck Labs, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78701
Party NameShattuck Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78701

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 25, 2023REGISTERED-PRINCIPAL REGISTER
Friday, June 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, June 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 26, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, May 1, 2023USE AMENDMENT FILED
Friday, May 26, 2023DIVISIONAL PROCESSING COMPLETE
Monday, May 1, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, May 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 1, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 1, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, November 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 10, 2022SOU EXTENSION 2 GRANTED
Thursday, November 10, 2022SOU EXTENSION 2 FILED
Thursday, November 10, 2022TEAS EXTENSION RECEIVED
Saturday, March 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 24, 2022SOU EXTENSION 1 GRANTED
Thursday, March 24, 2022SOU EXTENSION 1 FILED
Thursday, March 24, 2022TEAS EXTENSION RECEIVED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 17, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, August 17, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 17, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, August 17, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, May 10, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 10, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 22, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 22, 2021FINAL REFUSAL E-MAILED
Monday, February 22, 2021FINAL REFUSAL WRITTEN
Monday, February 1, 2021ASSIGNED TO EXAMINER
Thursday, January 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 29, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 29, 2020NON-FINAL ACTION WRITTEN
Sunday, July 26, 2020ASSIGNED TO EXAMINER
Tuesday, May 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 4, 2020NEW APPLICATION ENTERED

Related Keywords

gadlen pharmaceutical biotechnological proteins treatment fusion cancer diseases autoimmune form therapeutic